Obligation Barclay PLC 2.87% ( XS2088246942 ) en EUR

Barclay PLC

100 % ▲

Royaume-Uni

XS2088246942 ( en EUR )

2.87% par an ( paiement annuel )

23/04/2036

Prospectus brochure de l'obligation Barclays PLC XS2088246942 en EUR 2.87%, échéance 23/04/2036

100 000 EUR

75 000 000 EUR

23/04/2026 ( Dans 265 jours )

Barclays PLC est une banque multinationale britannique offrant une large gamme de services financiers, notamment la banque de détail, la gestion de patrimoine, la banque d'investissement et les cartes de crédit, opérant dans de nombreux pays à travers le monde.

Un nouvel instrument de dette est actuellement disponible sur le marché, émis par la multinationale bancaire britannique de premier plan, Barclays PLC. Barclays PLC, dont le siège est à Londres, est un acteur majeur et diversifié de l'industrie des services financiers, opérant à l'échelle mondiale. Fondée en 1690, elle dispose d'une présence significative dans la banque de détail, la banque d'entreprise et d'investissement, la gestion d'actifs et les cartes de crédit, ce qui en fait l'une des institutions financières les plus établies et les plus importantes au niveau international, régulièrement suivie par les investisseurs institutionnels. L'émission en question est une obligation libellée en euros (EUR), identifiée par le code ISIN XS2088246942, dont le pays d'émission est le Royaume-Uni. Cette obligation propose un taux d'intérêt fixe de 2,87%, avec une fréquence de paiement des coupons fixée à une fois par an, offrant ainsi une visibilité annuelle sur les rendements pour les porteurs. Sa date de maturité est fixée au 23 avril 2036, conférant à cet instrument une durée résiduelle significative. La taille totale de l'émission s'élève à 75 000 000 EUR, et le prix actuel sur le marché est de 100% de sa valeur nominale, ce qui signifie qu'elle se négocie au pair, indiquant une perception stable par le marché sans prime ni décote significative au moment de l'observation. La taille minimale d'achat pour cette obligation est fixée à 100 000 EUR, ciblant ainsi principalement les investisseurs institutionnels ou les particuliers à haute valeur nette désireux d'investir dans la dette d'une entité financière solide.

SECURITIES NOTE RELATING TO GSSP BASE PROSPECTUS 9

BARCLAYS BANK PLC
(Incorporated with limited liability in England and Wales)
LEI: G5GSEF7VJP5I7OUK5573
Pursuant to the Global Structured Securities Programme
What is this document?
This securities note (the "Securities Note" or the "Document"), together with the Registration Document
(as described below), constitutes a base prospectus drawn up as separate documents (the "Base
Prospectus") for the purposes of Article 8 of Regulation (EU) 2017/1129 (as amended, the "EU
Prospectus Regulation"). The Base Prospectus is one of a number of base prospectuses of Barclays
Bank PLC (the "Issuer") which relate to the Issuer's Global Structured Securities Programme (the
"Programme"). The Base Prospectus (as may be supplemented from time to time) is valid for 12 months
after its approval and will expire on 29 June 2023. The obligation to supplement a prospectus in the event
of any significant new factor, material mistake or material inaccuracy relating to the information included
in it does not apply when the prospectus is no longer valid.
What is the Registration Document?
The Issuer's registration document 9/2022 dated 1 June 2022 (as may be supplemented from time to time,
the "Registration Document") has been approved by the Central Bank of Ireland (the "CBI") pursuant
to the EU Prospectus Regulation. The Registration Document provides a description of the Issuer's
business activities as well as certain financial information and material risks faced by the Issuer. The
Registration Document and the supplements thereto are available for viewing at:
https://home.barclays/investor-relations/fixed-income-investors/prospectus-and-documents/structured-
securities-prospectuses/#registrationdocument
and
https://home.barclays/investor-relations/fixed-
income-investors/prospectus-and-documents/structured-securities-
prospectuses/#registrationdocumentsupplement.
What type of Securities does the Base Prospectus relate to?
The Base Prospectus ("GSSP Base Prospectus 9") relates to the issuance of securities ("Securities")
which will either not bear interest or pay any coupon or will bear interest or pay a coupon at either a
fixed rate or at a rate determined by reference to the performance of one or more Underlying Assets (as
described below), and may automatically redeem or cancel early (or 'autocall') if the Underlying Assets
are at or above a certain level on any one of a series of specified dates. Where the rate of interest or
coupon rate (as applicable) is determined by reference to the performance of one or more Underlying
Assets, the performance level could be subject to a foreign exchange conversion to reflect movements in
foreign exchange rates, and the amount of interest or coupon (as applicable) for any particular interest or
coupon period (as applicable) could be as low as zero. The Securities may be issued in Note, Certificate
or Exercisable Certificate form.
The Securities may or may not have an option to allow early redemption or cancellation by the Issuer
prior to the Scheduled Settlement Date. If not redeemed or cancelled early, the Securities will be
redeemed at a fixed redemption or cancellation amount or at an amount that is linked to the performance
of one or more Underlying Assets. The Securities may be specified to be redeemable in instalments.
In addition, the Issuer may issue "Green Structured Securities" and "Green Index Linked Securities"
under the Base Prospectus. See "Barclays Green Issuances Green Structured Securities" and "Barclays
Green Issuances Green Index Linked Securities" below.
Application has been made to the Irish Stock Exchange plc trading as Euronext Dublin ("Euronext
Dublin") for Securities (other than Excluded Securities) issued under the Programme during the period

1

of 12 months from the date of the Base Prospectus to be listed on the Official List of Euronext Dublin
and admitted to trading on its regulated market.
Who is the Issuer?
The Issuer of the Securities is Barclays Bank PLC. The delivery of property or payment of any amount
due under the Securities is subject to the Issuer's financial position and its ability to meet its obligations.
The legal entity identifier ("LEI") in respect of the Issuer is G5GSEF7VJP5I7OUK5573.
How do I use the Base Prospectus?
The Base Prospectus, together with certain other documents listed within, is intended to provide you with
information necessary to enable you to make an informed investment decision before purchasing any
Securities.
The contractual terms of any particular issuance of Securities will be composed of the terms and
conditions set out at pages 95 to 467 of this Securities Note (the "General Conditions"), as completed
by a separate Final Terms (as defined below) document, which is specific to that issuance of Securities.
The General Conditions comprise eight Sections (A to H):
·
Sections A: INTRODUCTION, B: FORM, TITLE, TRANSFER, CALCULATIONS,
PAYMENTS, EXERCISE AND SETTLEMENT and H: GENERAL PROVISIONS are generic
provisions which apply to issuances of Securities generally;
·
Sections C: INTEREST, COUPON, OPTIONAL EARLY SETTLEMENT, AUTOMATIC
SETTLEMENT (AUTOCALL), FINAL SETTLEMENT AND NOMINAL CALL EVENT, D:
EQUITY LINKED CONDITIONS AND DISRUPTION EVENTS, E: FX DISRUPTION
EVENTS AND ADJUSTMENTS, F. FUND LINKED CONDITIONS AND ADJUSTMENTS
and G. BARCLAYS INDEX LINKED CONDITIONS AND ADJUSTMENTS contain certain
optional provisions that will only apply to certain issuances of Securities. The Final Terms
document will specify which provisions from Sections C, D, E, F and G apply to your Securities.
The provisions from Section C that are specified to be applicable in the Final Terms will contain the
relevant economic terms applicable to your Securities, as follows:
·
General Condition 8 (Exercise of Exercisable Certificates) sets out the exercise procedures for
Securities which are Exercisable Certificates;
·
the relevant sub-paragraph of General Condition 9 (Interest) sets out how any interest or coupon
amounts (as applicable) will be calculated;
·
General Condition 10 (Automatic Settlement (Autocall)), if specified to apply in the Final Terms,
contains details on the calculation of the early redemption or cancellation amount which is
payable following an 'autocall event';
·
General Condition 11 (Optional Early Settlement Event), if specified to apply in the Final
Terms, contains details on the calculation of the early redemption or cancellation amount which
is payable where the Issuer elects to redeem the Securities prior to the Scheduled Settlement
Date;
·
General Condition 12 (Final Settlement) sets out how any settlement amount or entitlement will
be calculated upon redemption (in the event that the Securities do not redeem early);
·
General Condition 13 (Nominal Call Event Settlement), if specified to apply in the Final Terms,
contains details on the calculation of the early redemption or cancellation amount which is
payable following a 'nominal call event';
·
General Condition 14 (Switch Feature), if specified to apply in the Final Terms, sets out how a
switch option will apply; and

2

·
General Condition 15 (Settlement by Instalments), if specified to apply in the Final Terms, sets
out how the partial redemption in instalments feature will apply.
This Securities Note also includes other general information such as information about the material risks
relating to investing in Securities (see the section headed 'Risk Factors' of this Document) and
information on selling and transfer restrictions. The Registration Document provides a description of the
Issuer's business activities as well as certain financial information and material risks faced by the Issuer.
All capitalised terms used will be defined in the Base Prospectus or the Final Terms and are referenced
in the Index to this Document or the Index of Abbreviations to the Registration Document, as applicable.
What other documents do I need to read?
The Base Prospectus contains all information which is necessary to enable investors to make an informed
decision regarding the financial position and prospects of the Issuer and the rights attaching to the
Securities. Some of this information is incorporated by reference from other publicly available
documents and some of this information is completed in an issue-specific document called the Final
Terms. You should read the documents incorporated by reference, as well as the Final Terms in respect
of such Securities, together with the Base Prospectus. Documents will be made available at the registered
office of the Issuer and at https://home.barclays/investor-relations/fixed-income-investors/prospectus-
and-documents/structured-securities-prospectuses/,
https://home.barclays/investor-relations/fixed-
income-investors/prospectus-and-documents/structured-securities-final-terms
and
https://home.barclays/investor-relations/reports-and-events (as applicable) or the successor website(s).
What information is included in the Final Terms?
While this Document includes general information about all Securities, the Final Terms (or, in the case
of Excluded Securities, the Pricing Supplement) is the document that sets out the specific details of each
particular issuance of Securities (the "Final Terms"). For example, the Final Terms (or, in the case of
Excluded Securities, the Pricing Supplement) will contain:
·
the issue date;
·
the dates on which the Securities may redeem early due to an 'autocall event' or at the option of
the Issuer (in either case, if applicable);
·
the type of interest or coupon and the interest or coupon payment dates (if applicable);
·
the type of final redemption amount payable or entitlement deliverable (assuming that the
Securities do not redeem early) and the Scheduled Settlement Date;
·
the type of settlement amount payable or entitlement deliverable (assuming that the Securities
do not cancel early) and the exercise price; and
·
any other information needed to complete the terms included in this Document for the particular
Securities (identified by the words 'as specified in the Final Terms' or other equivalent wording).
Wherever the General Conditions provide optional provisions, the Final Terms will specify which of
those provisions apply to a specific issuance of Securities. In addition, an issue-specific summary will
be annexed to the Final Terms for each issuance of Securities which will contain a summary of key
information relating to the Issuer and the Securities, the risks relating to the Issuer and the Securities and
the issue or offer of Securities.
What type of Underlying Assets may the Securities be linked to?
The interest or coupon (in either case, if applicable) and final settlement terms of Securities issued under
the Base Prospectus may be linked to the performance of one or more of the following types of
'Underlying Assets': equity indices, shares, depository receipts representing shares, exchange-traded
funds, foreign exchange rates, funds and/or other indices (of one or more types of component assets)
sponsored by Barclays and referred to in this Document as "Barclays Indices".
What are Excluded Securities?

3

"Excluded Securities" are Securities: (i) for which no prospectus is required to be published for an
offering or listing of such Securities in the European Economic Area ("EEA") under the EU Prospectus
Regulation; or (ii) which have terms (for example, payout terms) not strictly provided for under the terms
herein but for which a separate prospectus (other than this Base Prospectus) is required to be published
under the EU Prospectus Regulation for the public offering of such Securities in the EEA or the listing
of such Securities on a regulated market in the EEA. Excluded Securities shall be issued by way of a
pricing supplement (the "Pricing Supplement") instead of Final Terms and, for such purpose, all
references to "Final Terms" herein shall be deemed to be to "Pricing Supplement". In respect of Excluded
Securities, each reference herein to "Base Prospectus" shall be construed instead to be to "Offering
Memorandum". The Offering Memorandum does not constitute a base prospectus for the purposes of
Article 8 of the EU Prospectus Regulation. The Central Bank of Ireland has neither approved nor
reviewed information contained herein in connection with Excluded Securities. See "Excluded
Securities" in the "General Description of the Programme" section below.
The Securities may not be offered, sold, transferred, pledged, assigned, delivered, exercised or redeemed
within the United States or to, or for the account or benefit of, any U.S. person except, in respect of
certain of the Securities, in accordance with Rule 144A under the U.S. Securities Act of 1933, or if
another exemption from registration under that act is available.

30 June 2022

4

Important Information
IMPORTANT INFORMATION
THE AMOUNT PAYABLE OR DELIVERABLE ON SETTLEMENT OR EXERCISE OF THE
SECURITIES MAY BE LESS THAN THE ORIGINAL INVESTED AMOUNT (AND IN SOME
CASES MAY BE ZERO), IN WHICH CASE YOU MAY LOSE SOME OR ALL OF YOUR
ORIGINAL INVESTMENT.
FOR ALL SECURITIES, IF THE ISSUER BECOMES INSOLVENT OR BANKRUPT OR
OTHERWISE FAILS TO MAKE ITS PAYMENT OR DELIVERY OBLIGATIONS ON THE
SECURITIES, YOU WILL LOSE SOME OR ALL OF YOUR ORIGINAL INVESTMENT.
INVESTING IN SECURITIES INVOLVES CERTAIN RISKS, AND YOU SHOULD FULLY
UNDERSTAND THESE BEFORE YOU INVEST. SEE THE SECTION HEADED 'RISK
FACTORS' BELOW.
Responsibility
The Issuer accepts responsibility for the information contained in this Securities Note (and for the
avoidance of doubt, in the Base Prospectus) and any Final Terms. To the best of the knowledge of the
Issuer, the information contained in this Securities Note is in accordance with the facts and this Securities
Note makes no omission likely to affect its import.
Regulatory approval and passporting for the purposes of the EU Prospectus Regulation
This Securities Note (and for the avoidance of doubt, the Base Prospectus) has been approved by the
Central Bank of Ireland as competent authority under the EU Prospectus Regulation. The Central Bank
of Ireland only approves the Securities Note as meeting the standards of completeness, comprehensibility
and consistency imposed by the EU Prospectus Regulation.
Such approval should not be considered as an endorsement of the Issuer or the quality of the securities
that are the subject of the Base Prospectus. Investors should make their own assessment as to the
suitability of investing in the securities.
Notification of this approval has been made to the competent authorities of Belgium, the Czech Republic,
Denmark, Finland, France, Hungary, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal,
Romania, Slovakia, Spain and Sweden.
Such approval relates only to Securities which are to be admitted to trading on a regulated market for the
purposes of Directive 2014/65/EU and Regulation (EU) No.600/2014 (as amended, "MiFID II") and/or
which are to be offered to the public in any Member State of the European Economic Area.
Listing and admission to trading
Applications may be made for the listing and admission to trading of Securities on the regulated market
of the Irish Stock Exchange plc trading as Euronext Dublin.
In addition, application may be made for a listing and admission to trading of Securities on the regulated
market of the Luxembourg Stock Exchange, Euronext Paris, Euronext Brussels, Euronext Amsterdam,
Malta Stock Exchange, NASDAQ Copenhagen, NASDAQ Helsinki, NASDAQ Stockholm, NGM
Nordic Derivatives Exchange (NDX), Oslo Stock Exchange, Borsa Italiana S.p.A., Bolsas y Mercados
Españoles and/or Euronext Lisbon, as specified in the Final Terms.
Application may also be made for a listing and admission to trading of Securities on the SIX Swiss
Exchange and/or on the multilateral trading facility of EuroTLX SIM S.p.A., Euro MTF, the Nasdaq
Structured Products MTF segment of Nasdaq First North Finland, Nasdaq Stockholm Structured
Products MTF, NGM Nordic MTF, SeDex (MTF) and/or Hi-MTF, as specified in the Final Terms. The
SIX Swiss Exchange and the multilateral trading facility of EuroTLX SIM S.p.A., Euro MTF, the Nasdaq
Structured Products MTF segment of Nasdaq First North Finland, Nasdaq Stockholm Structured
Products MTF, NGM Nordic MTF, SeDex (MTF) and/or Hi-MTF are not regulated markets for the
purposes of MiFID II.

5

Important Information
No compensation arrangements
Any failure by the Issuer to make payments or deliveries due under the Securities would not of itself give
rise to any claim for compensation on the grounds of such a failure. You would not have a claim for
compensation against the UK's Financial Services Compensation Scheme. For more information
regarding Issuer risk, please see the section headed 'Risk Factors' of the Registration Document.
No investment advice
Neither the Base Prospectus nor any Final Terms is or purports to be investment advice. Unless expressly
agreed otherwise with a particular investor, neither the Issuer nor any Manager is acting as an investment
adviser, providing advice of any other nature, or assuming any fiduciary obligation to any investor in
Securities.
Independent evaluation
Nothing set out or referred to in the Base Prospectus is intended to provide the basis of any credit or other
evaluation (except in respect of any purchase of Securities described herein) or should be considered as
a recommendation by the Issuer or any Manager that any recipient of the Base Prospectus (or any
document referred to herein) should purchase any Securities.
An investor should not purchase the Securities unless they understand the extent of their exposure to
potential loss. Investors are urged to read (i) the risks described in the section headed 'Risk Factors' of
this Document and (ii) the risks described in the section headed 'Risk Factors' of the Registration
Document, together with the other information in the Base Prospectus (including any information
incorporated by reference), as supplemented from time to time, and the Final Terms, before investing in
the Securities.
Investors should note that (i) the risks described in the section headed 'Risk Factors' of this Document
and (ii) the risks described in the section headed 'Risk Factors' of the Registration Document are not the
only risks that the Issuer faces or that may arise because of the nature of the Securities. The Issuer has
described only those risks relating to its operations and to the Securities that it considers to be material.
There may be additional risks that the Issuer currently considers not to be material or of which it is not
currently aware.
Given the nature, complexity and risks inherent in the Securities (and investments relating to any
underlying assets), the Securities may not be suitable for an investor's investment objectives in the light
of his or her financial circumstances. Investors should consider seeking independent advice to assist them
in determining whether the Securities are a suitable investment for them or to assist them in evaluating
the information contained or incorporated by reference into the Base Prospectus or set out in the Final
Terms.
You have sole responsibility for the management of your tax and legal affairs including making any
applicable filings and payments and complying with any applicable laws and regulations. Neither the
Issuer nor any of its Affiliates will provide you with tax or legal advice and you should obtain your own
independent tax and legal advice tailored to your individual circumstances. The tax treatment of
structured products, such as the Securities, can be complex; the tax treatment applied to an individual
depends on their circumstances. The level and basis of taxation may alter during the term of any product.
Amounts due to be paid to you are described on a gross basis, i.e. without calculating any tax liability.
The Issuer shall make no deduction for any tax, duty, or other charge unless required by law.
Potential for discretionary determinations by the Determination Agent and the Issuer under the
Securities
Under the terms and conditions of the Securities, following the occurrence of certain events relating to
the Issuer, the Issuer's hedging arrangements, the Underlying Asset(s), taxation, the relevant currency or
other matters, the Issuer or the Determination Agent may determine to take one of the actions available
to it in order to deal with the impact of such event on the Securities or the Issuer or both. These actions
may include (i) adjustment to the terms and conditions of the Securities, (ii) substitution of the
Underlying Asset(s) or (iii) early redemption or cancellation of the Securities. Any such discretionary
determination by the Issuer or Determination Agent could have a material adverse impact on the value

6

Important Information
of and return on the Securities. See, in particular, 'Risk Factors' risk factor 6.1 (Risks associated with
discretionary powers, or with respect to certain French Notes, decision-making powers, of the Issuer
and the Determination Agent, including in relation to the Issuer's hedging arrangements) below.
Under certain circumstances, amendments made by the Issuer or the Determination Agent to the
Conditions of French Notes may require the prior consent of the General Meeting of the Holders when
the 'Full Masse' or 'Contractual Masse' is specified as applicable in the Final Terms in accordance with
General Condition 60.3 (Modifications of French Notes).
Distribution
The distribution or delivery of the Base Prospectus or any Final Terms and any offer or sale of Securities
in certain jurisdictions may be restricted by law. The Base Prospectus does not constitute, and may not
be used for the purposes of, an offer or solicitation by anyone in any jurisdiction in which such offer or
solicitation is not authorised or to any person to whom it is unlawful to make such offering or solicitation.
Other than as expressly described in the Base Prospectus, no action is being taken to permit an offering
of Securities or the delivery of the Base Prospectus in any jurisdiction. Persons into whose possession
the Base Prospectus or any Final Terms comes are required by the Issuer to inform themselves about and
to observe any such restrictions.
Details of selling restrictions for various jurisdictions are set out in the section headed 'Purchase and
Sale' of this Document.
United States selling restrictions
In relation to Securities which are being offered and sold outside the United States in reliance on
Regulation S only, there are restrictions on the Issuer and its Affiliates (including Barclays Bank PLC in
its role as Manager) making sales of Securities in the United States, including for market making
purposes.
The Securities, and, as applicable, the Entitlements have not been and will not be, at any time, registered
under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities
regulatory authority of any state or other jurisdiction of the United States. Trading in the Securities and
the Entitlements has not been approved by the U.S. Commodities Futures Trading Commission under
the U.S. Commodity Exchange Act of 1936, as amended (the "Commodity Exchange Act"), and the
rules and regulations promulgated thereunder. The Securities, and, as applicable, the Entitlements, may
not be offered or sold within the United States, or to, or for the account or benefit of, U.S. persons (as
defined in Regulation S under the Securities Act ("Regulation S")) ("U.S. persons"), except in certain
transactions exempt from the registration requirements of the Securities Act and applicable state
securities laws. The Securities and, as applicable, the Entitlements are being offered and sold outside the
United States to non-U.S. persons in reliance on Regulation S.
Securities in bearer form may be subject to U.S. tax law requirements (as described below). Subject to
certain exceptions, such Securities may not be offered, sold or delivered within the United States or its
possessions or to, or for the account or benefit of, United States persons (as defined in the U.S. Internal
Revenue Code of 1986, as amended (the "Code"), and the regulations thereunder).
For a description of these and certain further restrictions on offers, sales and transfers of Securities and
delivery of the Base Prospectus and any Final Terms, see the section entitled 'Purchase and Sale' herein.
THE SECURITIES HAVE NOT BEEN AND WILL NOT BE APPROVED OR DISAPPROVED BY
THE U.S. SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES
COMMISSION IN THE UNITED STATES OR ANY OTHER U.S. REGULATORY AUTHORITY,
NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE
MERITS OF THE OFFERING OF SECURITIES OR THE ACCURACY OR THE ADEQUACY OF
THE OFFERING DOCUMENTS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENCE IN THE UNITED STATES.
US foreign account tax compliance withholding
THE FOREIGN ACCOUNT TAX COMPLIANCE ACT ("FATCA") IS PARTICULARLY
COMPLEX AND ITS CURRENT AND FUTURE APPLICATION TO THE ISSUER, THE

7

Important Information
SECURITIES AND INVESTORS IS UNCERTAIN AT THIS TIME. YOU SHOULD CONSULT
YOUR OWN TAX ADVISERS TO OBTAIN A MORE DETAILED EXPLANATION OF FATCA
AND TO LEARN HOW THIS LEGISLATION MIGHT AFFECT YOU IN YOUR
PARTICULAR CIRCUMSTANCE, INCLUDING HOW THE FATCA RULES MAY APPLY TO
PAYMENTS RECEIVED UNDER THE SECURITIES BOTH CURRENTLY AND IN THE
FUTURE.
Change of circumstances
Neither the delivery of the Base Prospectus (including any information incorporated by reference in the
Base Prospectus) or any Final Terms, nor any sale of Securities, shall create any impression that
information in such documents relating to the Issuer is correct at any time subsequent to the date of the
Registration Document (as supplemented) or that any other information supplied in connection with the
Securities or the Programme is correct as of any time subsequent to the date of the relevant document
containing the same (the foregoing being without prejudice to the Issuer's obligations under applicable
rules and regulations).
Unauthorised representations and solicitations
In connection with the issue and sale of Securities, no person has been authorised to give any information
or to make any representation not contained in or consistent with the Base Prospectus and Final Terms
and, if given or made, such information or representation must not be relied upon as having been
authorised by the Issuer. The Issuer does not accept responsibility for any information not contained in
the Base Prospectus and Final Terms. The Base Prospectus does not constitute, and may not be used for
the purposes of, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation
is not authorised or to any person to whom it is unlawful to make such offering or solicitation and no
action is being taken to permit an offering of the Securities or the distribution of the Base Prospectus in
any jurisdiction where action is required.
Representations in relation to Swiss Securities
If you purchase Swiss Securities, you shall be deemed to have agreed to be bound by the exercise of any
UK Bail-In Power by the Relevant UK Resolution Authority. See General Condition 3 (Contractual
acknowledgement of bail-in in respect of Swiss Securities).
Representations in relation to French Securities
If you purchase French Securities, you shall be deemed to have agreed to be bound by the exercise of
any UK Bail-In Power by the Relevant UK Resolution Authority General Condition 4 (Contractual
acknowledgement of bail-in in respect of French Securities).
Calculations and determinations
Unless otherwise specified, all calculations and determinations in respect of the Securities shall be made
by either Barclays Bank PLC or Barclays Capital Securities Limited (acting in such capacity, the
"Determination Agent").
Use of a benchmark
Amounts payable under the Securities or assets deliverable under the Securities may be calculated or
otherwise determined by reference to an index or a combination of indices. Any such index may
constitute a benchmark for the purposes of Regulation (EU) 2016/1011 (as amended, the "EU
Benchmarks Regulation"). If any such index does constitute such a benchmark, the Final Terms will
indicate whether or not the benchmark is provided by an administrator included in the register of
administrators and benchmarks established and maintained by the European Securities and Markets
Authority ("ESMA") pursuant to Article 36 of the EU Benchmarks Regulation. Not every index will fall
within the scope of the EU Benchmarks Regulation. Transitional provisions in the EU Benchmarks
Regulation may have the result that the administrator of a particular benchmark is not required to appear
in the register of administrators and benchmarks at the date of the applicable Final Terms. The
registration status of any administrator under the EU Benchmarks Regulation is a matter of public record
and, save where required by applicable law, the Issuer does not intend to update the Final Terms to reflect
any change in the registration status of the administrator.

8

Important Information
Language
The language of this Base Prospectus is English. Certain legislative references and technical terms have
been cited in their original language in order that the correct technical meaning may be ascribed to them
under applicable law.
Definitions relating to Barclays entities
In this Document, "Group" or "Barclays" mean Barclays PLC together with its subsidiaries, the terms
"Barclays Bank Group" means Barclays Bank PLC together with its subsidiaries and the terms
"Barclays Group" means Barclays Bank PLC and Barclays PLC together with their subsidiaries.

9

TABLE OF CONTENTS
RISK FACTORS
13
This section sets out the principal risks inherent in investing in Securities issued

pursuant to the Programme, including key risks relating to investments linked to the
Underlying Asset(s).
GENERAL DESCRIPTION OF THE PROGRAMME
82
This section provides an overview of certain key features of the Programme.

INFORMATION INCORPORATED BY REFERENCE
89
This section incorporates certain information in respect of the Securities.

TERMS AND CONDITIONS OF THE SECURITIES
95
This section sets out the contractual terms of the Securities. Section C contains certain

options for determining interest payments (if any), optional redemption rights (if any)
and final redemption payments and the Final Terms will indicate which of these
options shall apply.
A.
INTRODUCTION ......................................................................................................................
B.
FORM, TITLE, TRANSFER, CALCULATIONS, PAYMENTS, EXERCISE AND
SETTLEMENT ..........................................................................................................................
1
Form, Title and Transfer ............................................................................................. 98
2
Status ......................................................................................................................... 106
3
Contractual acknowledgement of bail-in in respect of Swiss Securities ................... 106
4
Contractual acknowledgement of bail-in in respect of French Securities ................. 107
5
Calculations and Publication ..................................................................................... 107
6
Payments and Deliveries ........................................................................................... 109
7
Settlement.................................................................................................................. 113
8
Exercise of Exercisable Certificates .......................................................................... 119
C.
INTEREST, COUPON, OPTIONAL EARLY SETTLEMENT, AUTOMATIC SETTLEMENT
(AUTOCALL), FINAL SETTLEMENT AND NOMINAL CALL EVENT .............................
9
Interest ....................................................................................................................... 120
10
Automatic Settlement (Autocall) .............................................................................. 213
11
Optional Early Settlement Event ............................................................................... 217
12
Final Settlement ........................................................................................................ 220
13
Nominal Call Event Settlement ................................................................................. 294
14
Switch Feature ........................................................................................................... 295
15
Settlement by Instalments ......................................................................................... 296
D.
EQUITY LINKED CONDITIONS AND DISRUPTION EVENTS
16
Equity Index Modification, Cancellation, Disruption or Adjustment Event ............. 297
17
Share Adjustments or Disruptions ............................................................................. 300
18
Consequences of Disrupted Days .............................................................................. 302
19
Adjustments .............................................................................................................. 305
20
Fund Components ..................................................................................................... 305
E.
FX DISRUPTION EVENTS AND ADJUSTMENTS
21
Consequences of FX Disruption Events (FX) ........................................................... 305
22
Replacement of a Currency ....................................................................................... 307
23
Corrections to Published and Displayed Rates .......................................................... 307
24
Postponements of Payments ...................................................................................... 308
25
Depository Receipt Provisions .................................................................................. 308
F.
FUND LINKED CONDITIONS AND ADJUSTMENTS
26
Adjustments to Valuation Dates and Reference Dates .............................................. 314
27
Fund Events............................................................................................................... 317
28
Consequences of a Fund Event ................................................................................. 322
29
Potential Adjustment of Payment Events .................................................................. 325
30
Consequences of a Potential Adjustment of Payment Event ..................................... 326

10